Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia.

Girbash, Ehab F; Sherif, Hala E; Radwan, Ahmed M; Abdeldayem, Hussein M

Girbash, Ehab F; Sherif, Hala E; Radwan, Ahmed M; Abdeldayem, Hussein M.

Afiliação

Girbash EF; Obstetrics and Gynecology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. ehab_fg@hotmail.com.
Sherif HE; Obstetrics and Gynecology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Radwan AM; Obstetrics and Gynecology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Abdeldayem HM; Obstetrics and Gynecology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Arch Gynecol Obstet ; 308(3): 947-952, 2023 09.

Article em En | MEDLINE | ID: mdl-37010614

Assuntos

Hiperplasia Endometrial; Nandrolona; Feminino; Humanos; Masculino; Acetato de Noretindrona; Hiperplasia Endometrial/tratamento farmacológico; Hiperplasia Endometrial/patologia; Nandrolona/uso terapêutico; Endométrio/patologia; Noretindrona/uso terapêutico; Estradiol

Palavras-chave

Dienogest; Endometrial hyperplasia without atypia; Norethisterone acetate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia Endometrial / Nandrolona Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Arch Gynecol Obstet Assunto da revista: GINECOLOGIA / OBSTETRICIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google